Dexrazoxane Injection, Powder, Lyophilized, For Solution
Product Images NDC 72205-248

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dexrazoxane (NDC 72205-248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dexra-inj-250mg-cntr-label (Dexra Inj 250mg Cntr Label)

Label for Dexrazoxane for Injection, 250 mg per vial, lyophilized powder for intravenous use. The single-dose vial is sterile and pyrogen-free. Distributed by Novadoz Pharmaceuticals LLC. The label includes storage instructions, reconstitution details, and manufacturer information (MSN Laboratories Private Limited, India).*

FDA Label Image

Dexra-inj-250mg-crtn-label (Dexra Inj 250mg Crtn Label)

The image shows a carton label for Dexrazoxane for Injection, 250 mg per vial. It is a sterile, pyrogen-free lyophilized powder for intravenous use, distributed by Novadoz Pharmaceuticals LLC and manufactured by MSN Laboratories Private Limited, India. The packaging indicates a single-dose vial with storage and preparation instructions.*

FDA Label Image

Dexra-inj-500mg-cntr-label (Dexra Inj 500mg Cntr Label)

Label for Dexrazoxane for Injection 500 mg/vial, sterile lyophilized powder for intravenous use. The single-dose vial is distributed by Novadoz Pharmaceuticals LLC and manufactured by MSN Laboratories Private Limited, India. The label includes storage instructions, reconstitution guidance, and a barcode.*

FDA Label Image

Dexra-inj-500mg-crtn-label (Dexra Inj 500mg Crtn Label)

Packaging label for Dexrazoxane for Injection 500 mg per vial, a sterile, pyrogen-free lyophilized powder for solution intended for intravenous use. The label shows single-dose vial packaging by Novadoz Pharmaceuticals LLC, including storage instructions, manufacturer details (MSN Laboratories, India), and barcode information. The label emphasizes that the product is prescription-only.*

FDA Label Image

Dexra-inj-fig-01 (Dexra Inj Fig 01)

A bar chart comparing the number of patients in two treatment groups (FAC/Dexrazoxane and FAC) across cumulative doses of doxorubicin (mg/m²). The x-axis shows dose ranges from 350 to 1000+ mg/m², and the y-axis represents the number of patients. FAC/Dexrazoxane group bars are white, and FAC group bars are black, illustrating patient distribution by dose.*

FDA Label Image

Dexra-inj-structure (Dexra Inj Structure)

Chemical structure of Dexrazoxane, showing its characteristic bicyclic ring system with two amide groups and a chiral center bearing a methyl group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.